The FY2021-1 Small Business Innovation Research Contract (SBIR) Program solicitation has been posted!
“The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invite small business concerns (SBCs) to submit research proposals under this Small Business Innovation Research (SBIR) Contract Solicitation. Firms with the capability to conduct research and development (R&D) in any of the health-related topic areas described in Section 12.0, and to commercialize the results of that R&D, are encouraged to participate. Some Topics allow for only a Phase I proposal to be submitted at this time. Some Topics allow for only a Phase II proposal to be submitted, through the ‘Direct to Phase II’ process. Some Topics allow for ‘Fast Track’ proposals, which include both a Phase I proposal and a Phase II proposal.” (Full listing below).
Contract funding is very different from grant funding, and a project needs to be a very (very) good fit to pursue this mechanism. NIAID offers a useful resource to compare differences between grants and contracts – although written specifically for NIAID, these guidelines generally apply across NIH contracts.
Wondering if your company could win non-dilutive funding through an SBIR contract? Have questions about understanding the solicitation details? Reach out today and we will connect you with one of our experts!
FY2021 NCI SBIR Contract Topics:
-
Topic 413 – Next Generation 3D Tissue Culture Systems with Tertiary Lymphoid Organs
-
Topic 414 – Synthetic Biology Gene Circuits for Cancer Therapy
-
Topic 415 – Applicator-Compatible Electronic Brachytherapy Sources for Cancer Radiotherapy
-
Topic 416 – Self-Sampling Devices for HPV-Testing-Based Cervical Cancer Screening
-
Topic 417 – Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning
-
Topic 418 – 3D Spatial Omics for Molecular and Cellular Tumor Atlas Construction
-
Topic 419 – Understanding Cancer Tumor Genomic Results: Technology Applications for Providers
-
Topic 420 – Single-Cell “Unbiased Discovery” Proteomic Technologies
-
Topic 421 – Quantitative Biomimetic Phantoms for Cancer Imaging and Radiation Dosimetry
-
Topic 422 – Spatial Sequencing Technologies with Single Cell Resolution for Cancer Research and Precision Medicine
-
Topic 423 – Software to Address Social Determinants of Health in Oncology Practices
-
Topic 424 – Digital Tools to Improve Health Outcomes in Pediatric Cancer Survivors
-
Topic 426 – Tools and Technologies for Visualizing Multi-Scale Data
-
Topic 427 – De-Identification Software Tools and Pipelines for Cancer Imaging Research
-
Topic 428 – Cloud-Based Multi-Omic and Imaging Software for the Cancer Research Data Commons
-
Topic 429 – Advanced Manufacturing to Speed Availability of Emerging Autologous Cell-Based Therapies
Are you ready to get started on winning the non-dilutive funding your company needs?
Recent Comments